ArticleDialogues in clinical neuroscience2026
Causal links between gut microbiota, plasma metabolites, and insomnia: Insights from Mendelian randomization.
Article in Dialogues in clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study explored the plasma metabolites' mediation effect between gut microbiomes and insomnia through Mendelian randomisation (MR).
methodsUsing publicly accessible GWAS data from 5959 individuals for gut microbiota and 8299 individuals for plasma metabolites, we employed MR analysis to explore their causal effects on insomnia. Insomnia outcome data were obtained from Pan-UKB, GERA, and FinnGen, covering 9007 cases and 871,802 controls. Mediation effects of identified bacterial taxa on insomnia through plasma metabolites were computed using the product of coefficients approach.
resultsOur MR analysis included participants with a mean age of 45.7 years (SD = 11.5) for gut microbiota and 63 years (range 45-85) for plasma metabolites. The analysis identified 10 gut microbiomes and 35 plasma metabolites potentially associated with insomnia respectively. Specifically, increased abundances of certain gut microbiomes, such as species
conclusionThis study highlights the role of gut microbiota in influencing insomnia risk, mediated through specific plasma metabolites. These findings provide valuable insights into the gut-brain axis and may inform the development of therapeutic targets for managing sleep disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.